Clinical trials / NCT06596135
NCT06596135Phase 3Completed

Open-Label Extension Study of Setmelanotide

Study sponsor: Rhythm Pharmaceuticals, Inc. · RYTM

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov recordCSV export · Pro
Primary completion2026-06-24Actual
Enrollment · participants28Actual
Source updated2026-07-15Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 5 fields changed

Participant count type changed

− Before

Estimated

+ After

Actual

Enrollment · participant count changed

− Before

30 participants (planned)

+ After

28 participants (actual)

Completion date type changed

− Before

Estimated

+ After

Actual

Primary completion date changed

− Before

30 Oct 2027

+ After

24 Jun 2026

Recruitment status changed

− Before

Enrolling by invitation

+ After

Completed

Check registry source